Literature DB >> 15657693

[Ranking of systemic steroids after normal-risk keratoplasty. Results of a randomized prospective study].

S Mayweg1, T Reinhard, H Spelsberg, A Reis, E Godehardt, R Sundmacher.   

Abstract

BACKGROUND: The aim of this study was to evaluate the efficacy of sole application of topical steroids after normal-risk keratoplasty. PATIENTS AND METHODS: This randomized prospective clinical study assessed 40 patients who had undergone penetrating normal-risk keratoplasty. Twenty patients were treated exclusively with prednisolone acetate 1% eye drops 5x/day for 6 months postoperatively. Another 20 patients additionally received systemic fluocortolone 1 mg/kg body weight per day tapered within 3 weeks postoperatively. The main outcome measures included clear graft survival, ratio of graft rejection, and side effects.
RESULTS: The mean postoperative follow-up was 18+/-9 months. Three graft rejections were observed in the group receiving only topical steroids. Two graft rejections were observed in the group administered combined systemic and topical steroid therapy. None of the patients has developed irreversible graft failure so far.
CONCLUSION: Sole topical steroid application seems to be an effective immune prophylaxis in patients undergoing penetrating normal-risk keratoplasty.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657693     DOI: 10.1007/s00347-004-1148-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  21 in total

1.  Current Australian practice in the prevention and management of corneal allograft rejection.

Authors:  N H Barker; T R Henderson; C A Ross; D J Coster; K A Williams
Journal:  Clin Exp Ophthalmol       Date:  2000-10       Impact factor: 4.207

2.  Current practices in the prevention and treatment of corneal graft rejection.

Authors:  J R Rinne; R D Stulting
Journal:  Cornea       Date:  1992-07       Impact factor: 2.651

Review 3.  Gene regulation by steroid hormones.

Authors:  M Beato
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

4.  [Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor].

Authors:  T Reinhard; R Sundmacher; E Godehardt; P Heering
Journal:  Ophthalmologe       Date:  1997-07       Impact factor: 1.059

5.  Cross-matches on donor cadaver retinal pigment epithelial cells in corneal risk patients.

Authors:  N Zavazava; B Nölle; G Duncker; S Jenisch; E Westphal; V Eckstein; W Müller-Ruchholtz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

6.  Corticosteroids in 100 keratoplasties.

Authors:  J N Buxton; J G Apisson; F B Hoefle
Journal:  Am J Ophthalmol       Date:  1969-01       Impact factor: 5.258

7.  DNA-based HLA class II postmortem typing: evaluation of different techniques for prospective corneal allografting.

Authors:  S Jenisch; E Westphal; N Zavazava; C Dürr; G Duncker; B Nölle; W Müller-Ruchholtz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

8.  Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty.

Authors:  C Cursiefen; H Wenkel; P Martus; A Langenbucher; N X Nguyen; B Seitz; M Küchle; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-07       Impact factor: 3.117

9.  Corneal graft survival in HLA-A- and HLA-B-matched transplantations in high-risk cases with retrospective review of HLA-DR compatibility.

Authors:  W H Beekhuis; G van Rij; J G Renardel de Lavalette; E Rinkel-van Driel; G Persijn; J D'Amaro
Journal:  Cornea       Date:  1991-01       Impact factor: 2.651

10.  The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.